Seeking Alpha

Shares of China Medical (CMED -19.5%) plunge after Glaucus Research alleges the medical device...

Shares of China Medical (CMED -19.5%) plunge after Glaucus Research alleges the medical device maker's CEO "orchestrated an acquisition to embezzle roughly $20-$23 million from the public company." Glaucus says CMED overpaid for the acquisition from an entity it believes is secretly related to the company's CEO. CMED denies the allegations.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs